Stock CRDL CARDIOL THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Cardiol Therapeutics Inc.

Equities

CRDL

CA14161Y2006

Delayed Toronto S.E.
Other stock markets
 10:36:21 2024-04-29 am EDT 		5-day change 1st Jan Change
2.4 CAD -2.04% Intraday chart for Cardiol Therapeutics Inc. -1.64% +118.18%
Apr. 22 HC Wainwright Starts Cardiol Therapeutics With Buy Rating, $9 Price Target MT
Apr. 01 Cardiol Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cardiol Therapeutics Inc. Announces Board Appointments
CI
Cardiol Therapeutics Inc. Announces Board and Committee Changes
CI
Cardiol Therapeutics Inc. Announces Board Appointments
CI
Cardiol Therapeutics Inc. Announces Board Changes
CI
Cardiol Therapeutics Inc. Announces Executive Changes
CI
Cardiol Therapeutics Inc. Appoints Andrew Hamer as Chief Medical Officer
CI
Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company's Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with Covid-19
CI
Cardiol Therapeutics Inc. Appoints Steven Grasso as Business Advisor
CI
Cardiol Therapeutics Inc. Announces Executive Changes
CI
Cardiol Therapeutics Inc. Announces Board Changes
CI
Cardiol Therapeutics Inc. Appoints Thomas Moffatt as Chief Commercial Officer
CI
Cardiol Therapeutics Announces Management Changes
CI
Cardiol Therapeutics Inc. Announces Board Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CRDL Stock
  4. News Cardiol Therapeutics Inc.
  5. Insiders